FDA Approves Amgen's Prolia(TM) (Denosumab) For Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture
Links shared publicly online about this topic.
- 963total visits
FDA Approves Amgen's Prolia(TM) (Denosumab) For Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture
View full resource at medicalnewstoday.com
Tags: Fracture, Osteoporosis, Osteoporosis Medication, Women's Health, FDA, Prolia, Amgen
Most Recently Shared on August 8, 2010 at 4:48 pm By:
FDA Approves Amgen's Prolia(TM) (Denosumab) For Treatment Of Postmenopausal Women With Osteoporosis At High Risk F... http://mnt.to/f/3H7P
Also Shared By:
FDA Approves Amgen's Prolia (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
drugs.com — “Prolia (denosumab) is used to treat postmenopausal women with osteoporosis. Includes Prolia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 2, 2010 at 11:55 pm By:
FDA Approves Prolia (denosumab) for Treatment of Postmenopausal Women With Osteoporosis - http://bit.ly/aF8OQu
Prolia approved for postmenopausal osteoporosis - MPR
empr.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at empr.com
Most Recently Shared on June 2, 2010 at 3:36 pm By:
Prolia approved for postmenopausal osteoporosis: The FDA has approved Prolia (denosumab, from Amgen) for the treat... http://bit.ly/cUXDUl
Prolia approved for postmenopausal osteoporosis - MPR
empr.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at empr.com
Most Recently Shared on June 2, 2010 at 3:17 pm By:
MPR News: Prolia approved for postmenopausal osteoporosis: The FDA has approved Prolia (denosumab, from Amgen) for... http://bit.ly/a0ZOXp
Prolia approved for postmenopausal osteoporosis - ONA
oncologynurseadvisor.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 2, 2010 at 3:00 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Prolia approved for postmenopausal osteoporosis http://goo.gl/fb/bGLvd
Advertisement
Women's Health Line
@WomensHealth_HL
FDA Approves Amgen's Prolia(TM) (Denosumab) For Treatment Of Postmenopausal Women With Osteoporosis At... http://sns.ly/zJe48 #womenshealth
1 year ago...